Medio Labs is an innovative biotechnology company that has developed the patent-pending platform, MedioSeq, which offers pathogen detection labs an opportunity to significantly increase throughput, lower cost and generate more data faster through a conversion of their qPCR panels to a consolidated NGS workflow.  With MedioSeq enabling the everyday use of NGS, it is now possible to process more panels, targets per panel and samples with less space, personnel, instruments and consumables.  

MedioSeq’s broad applications include human diagnostics, as well as veterinary, agricultural, environmental and food testing.  

Having successfully used its own innovation of MedioSeq to process thousands of Covid-19 samples per day during the height of the pandemic, Medio Labs is now focused on helping labs process their pathogen panels with greater scale and efficiency.  

To discuss streamlining your pathogen testing workflows with MedioSeq, send an email to info@medio.ai and we will be in touch!

Medio Labs

Org chart

Teams

Offices